Both in Pharmaceuticals
Xenetic Biosciences vs Traws Pharma
Over the past year XBIO returned −34.0% and TRAW returned −87.4%; their daily moves had a correlation of 0.06.
XBIO −34.0% TRAW −87.4%Growth of $1, one year, split-adjusted
| Metric | XBIO | TRAW |
|---|---|---|
| Price | $2.06 | $0.3003 |
| Market cap | $4.8M | $4.6M |
| Today | +0.49% | +1.45% |
| 1 month | −8.0% | −47.2% |
| 6 months | −30.4% | −80.1% |
| Year to date | −5.1% | −73.4% |
| 1 year | −37.4% | −88.6% |
| Revenue growth (YoY) | +12.0% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $6.5M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 158.8% | 79.5% |
| Short % of float | 0.5% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).